-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target

Benzinga·06/24/2025 13:47:38
Listen to the news
JMP Securities analyst Jonathan Wolleben reiterates Skye Bioscience (NASDAQ:SKYE) with a Market Outperform and maintains $15 price target.